Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States.

Prozialeck, Walter C; Lamar, Peter C; Krupp, Michael; Moon, Matthew; Phelps, Laura E; Grundmann, Oliver

Prozialeck, Walter C; Lamar, Peter C; Krupp, Michael; Moon, Matthew; Phelps, Laura E; Grundmann, Oliver.

Afiliación

Prozialeck WC; Department of Pharmacology, Midwestern University, Downers Grove, IL, United States.
Lamar PC; Department of Pharmacology, Midwestern University, Downers Grove, IL, United States.
Krupp M; Department of Pharmacology, Midwestern University, Downers Grove, IL, United States.
Moon M; Department of Pharmacology, Midwestern University, Downers Grove, IL, United States.
Phelps LE; Department of Pharmacology, Midwestern University, Downers Grove, IL, United States.
Grundmann O; Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL, United States.

Front Pharmacol ; 12: 729220, 2021.

Article en En | MEDLINE | ID: mdl-34512353

Palabras clave

COVID-19 pandemic; drug abuse; kratom; opioid crisis; opioid use disorder

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos